Walnut Creek, California Clinical Trials

A listing of Walnut Creek, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 74 clinical trials
A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease

The researchers are doing this study to see if semaglutide can slow down the growth and worsening of chronic kidney disease in people with type 2 diabetes. Participants will get semaglutide (active medicine) or placebo ('dummy medicine'). This is known as participants' study medicine - which treatment participants get is …

angiotensin converting enzyme
semaglutide
renal impairment
chronic disease
Novo Nordisk Investigational Site
 (5.2 away) Contact site
  • 960 views
  • 02 Dec, 2020
  • +519 other locations
Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms

To assess the efficacy and safety of larazotide acetate versus placebo for the relief of persistent symptoms in adult celiac disease patients.

diarrhea
gluten
bloating
abdominal pain
serologic test
Innovate Research Site
 (2.2 away) Contact site
  • 823 views
  • 02 Dec, 2020
  • +189 other locations
Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer

This randomized phase III trial studies how well pembrolizumab works in treating patients with bladder cancer that has spread into the deep muscle of the bladder wall (muscle-invasive) or urothelial cancer that has spread from where it started to nearby tissue or lymph nodes (locally advanced). Monoclonal antibodies recognizing and …

Epic Care Cyberknife Center
 (0.7 away) Contact site
  • 836 views
  • 02 Dec, 2020
  • +725 other locations
A Phase 3 Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata (THRIVE-AA1)

This is a multi-center Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called CTP-543) in adults (18 years and older) who have 50% or greater scalp hair loss. The study is placebo-controlled, meaning that some patients entering the study will not receive active study …

Kaiser Permanente
 (9.6 away) Contact site
  • 0 views
  • 22 Nov, 2020
  • +57 other locations
Phase III Double-blind Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

The aim of the study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the prevention of COVID-19.

SARS
covid-19
Research Site
 (9.7 away) Contact site
  • 241 views
  • 22 Nov, 2020
  • +88 other locations
Efficacy Against Oral Persistent Infection Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

The purpose of this study is to evaluate the efficacy, immunogenicity and safety of the 9-valent human papillomavirus (9vHPV) vaccine in men 20 to 45 years of age. The primary hypothesis tested in this study is that administration of a 3-dose regimen of 9vHPV vaccine will reduce the incidence of …

persistent infection
dose regimen
human papillomavirus
v503
hpv vaccine
Diablo Clinical Research, Inc ( Site 0042)
 (4.7 away) Contact site
  • 433 views
  • 02 Dec, 2020
  • +106 other locations
S1803 Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Patients are enrolled to screening (Reg Step 1) prior to or after ASCT but prior to Reg Step 2. Patients are followed until they will begin Maintenance and then registered to Reg Step 2 (first randomization). Patients are randomized between Lenalidomide for 2 years and Lenalidomide + Daratumumab/rHuPH20. After 2 …

aspirin
warfarin
lenalidomide
daratumumab
heparin
Kaiser Permanente-Walnut Creek
 (2.8 away) Contact site
  • 86 views
  • 08 Oct, 2020
  • +529 other locations
SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

This study compares the effect and safety of 2 dose schedules for semaglutide (study medicine) in people with type 2 diabetes previously treated with a diabetes medicine similar to semaglutide. The study will also evaluate the use of a new pen-injector for semaglutide used to inject medicine under the skin, …

antidiabetic agents
glucagon-like peptide-1
alpha-glucosidase inhibitor
glucagon-like peptide 1
dipeptidyl peptidase-4 inhibitor
Novo Nordisk Investigational Site
 (2.2 away) Contact site
  • 139 views
  • 11 Nov, 2020
  • +33 other locations
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

The reason for this study is to see if the study drug mirikizumab is safe and effective in participants with moderately to severely active Crohn's disease.

crohn's disease
ustekinumab
Care Access - Ygnacio Valley
 (4.7 away) Contact site
  • 646 views
  • 27 Nov, 2020
  • +891 other locations
A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Patients That Are Not Helped by Previous Preventive Treatments

Evaluation of eptinezumab in the prevention of migraine in patients with unsuccessful prior preventive treatments

chronic migraine
triptan
headache
Diablo Clinical Research (US0006)
 (4.7 away) Contact site
  • 305 views
  • 04 Nov, 2020
  • +102 other locations